跳至主要内容
临床试验/NL-OMON29148
NL-OMON29148尚未招募不适用

Evaluation of pharmacokinetic and –dynamic characteristics of norepinephrine for the augmentation of arterial blood pressure in healthy volunteers prior to and during general anesthesia

niversity Medical Center Groningen, dept of Anaesthesiology0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ?American Society of Anesthesiologists (ASA) Physical Status I or II
  • ?No exclusion criterion is present
  • ?Informed, and willing to give written informed consent.

排除标准

  • ?Refusal of the volunteer to participate
  • ?Diseases involving the cardiovascular system (hypertension, coronary artery disease, prior acute myocardial infarction, any valvular and/or myocardial disease involving decrease in ejection fraction, arrhythmias, which are either symptomatic or require continuous medication/pacemaker/automatic internal cardioverter defibrillator)
  • ?A difference > 15 mmHg in measured systolic or diastolic blood pressure value (SBP, DBP) between the left and right upper arm, as determined by non-invasive cuff oscillometry during the screening visit.
  • ?An increased risk of difficult mask ventilation or tracheal intubation, as judged by the anesthesiologist-researcher.
  • ?Pulmonary disease
  • ?Gastric or endocrinologic diseases
  • ?End-stage liver or kidney failure
  • ?Use of tricyclic antidepressive medication or MAO inhibitors.

研究者

发起方
niversity Medical Center Groningen, dept of Anaesthesiology

相似试验

进行中(未招募)
1 期
What is the effect of bloodpressure increasing medication before and after anesthesiaBloodpressure during anaesthesia
EUCTR2020-005886-15-NLniversity Medical Center Groningen36
已完成
不适用
Evaluation of pharmacokinetic and *dynamic characteristics of norepinephrine for the augmentation of arterial blood pressure in healthy volunteers prior to and during general anesthesiageneral anaesthesianarcosesleep medication
NL-OMON51910niversitair Medisch Centrum Groningen36
进行中(未招募)
1 期
Evaluation du raltégravir pendant le troisième trimestre de la grossesseHIV and pregnancyMedDRA version: 18.0Level: LLTClassification code 10073025Term: Prevention of mother to child transmission of HIV infectionSystem Organ Class: 100000004865
EUCTR2013-004571-12-FRInserm-ANRS72
已完成
不适用
The evaluation of pharmacokinetic and pharmacodynamic properties of Propiverine Hydrochloride transdermal formulatiooveractive bladder
JPRN-UMIN000011937Dept of Clinical Pharmacology and Therapeutics, Oita University Faculty of Medicine10
进行中(未招募)
不适用
Evaluation of the reduction in heart rate, of the quantity of drug in the plasma and of the safety after different ascending oral doses of the active substance or a placebo in heart failure patients with a reduction of left ventricular ejection fraction (i.e. thequantity of blood the heart is able to eject in the body at each heart beat).
EUCTR2013-003000-39-EEInstitut de Recherches Internationales Servier125